Rising DLBCL & MCL Cases by 2032: SEER & Medicare Data Highlights Payer Strain & Demand for Brukinsa, Calquence, CAR-T
The number of women diagnosed with mantle cell lymphoma (MCL) is projected to rise through 2032, according to SEER and Medicare data, intensifying pressure on healthcare systems and treatment access. ... Read More